机译:The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA)
Department of Medicine Solna Division of Rheumatology Karolinska University Hospital at Karolinska Institutet;
Department of Public Health and Clinical Medicine/Rheumatology Umeå University;
Department of Rheumatology and Inflammation Research Sahlgrenska Academy University of GothenburgDepartment of Clinical Sciences Lund Section for Nephrology Lund University Lund and Skåne University HospitalDepartment of Protein Science SciLifeLab KTH Royal Institute of TechnologyDepartment of Biomedical and Clinical Sciences Division of Inflammation and Infection/Rheumatology Linköping UniversityCentral Hospital in Kristianstad Department of Infectious Diseases and Department of Clinical Sciences Section for Rheumatology Lund UniversityDepartment of Clinical Sciences Lund Section for Rheumatology Lund University and Skåne University Hospital;
Abatacept; Antibody response; COVID-19 vaccine; Immunogenicity; Inflammatory rheumatic disease; Methotrexate; Rituximab;